Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Thermo Fisher ( (TMO) ) just unveiled an announcement.
On October 29, 2025, Thermo Fisher Scientific announced a definitive agreement to acquire Clario Holdings, Inc. for approximately $8.875 billion in cash, with additional contingent payments. Clario, a provider of endpoint data solutions for clinical trials, will enhance Thermo Fisher’s capabilities in delivering clinical insights and accelerating the digital transformation of clinical research. This acquisition is expected to be completed by mid-2026, subject to regulatory approvals, and will be immediately accretive to Thermo Fisher’s adjusted earnings per share. The transaction aims to strengthen Thermo Fisher’s position as a trusted partner to pharma and biotech customers, offering deeper clinical insights and improved decision-making capabilities.
The most recent analyst rating on (TMO) stock is a Buy with a $656.00 price target. To see the full list of analyst forecasts on Thermo Fisher stock, see the TMO Stock Forecast page.
Spark’s Take on TMO Stock
According to Spark, TipRanks’ AI Analyst, TMO is a Outperform.
Thermo Fisher’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust profitability and strategic initiatives, such as collaborations and acquisitions, support its growth outlook. However, technical indicators suggest the stock may be overbought, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
To see Spark’s full report on TMO stock, click here.
More about Thermo Fisher
Thermo Fisher Scientific Inc. is a global leader in serving science, with annual revenue exceeding $40 billion. The company supports customers in accelerating life sciences research, solving analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Thermo Fisher offers a combination of innovative technologies, purchasing convenience, and pharmaceutical services through its industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
Average Trading Volume: 2,142,115
Technical Sentiment Signal: Strong Buy
Current Market Cap: $210.6B
See more data about TMO stock on TipRanks’ Stock Analysis page.